Pregnancy-associated exosomes and their modulation of T cell signaling

Journal of Immunology

Volumn 176, Issue 3, 2006, Pages 1534-1542

  Taylor, Douglas D ^a   Akyol, Sibel ^a   Gercel Taylor, Cicek ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FAS LIGAND; HLA DR ANTIGEN; INTERLEUKIN 2; JANUS KINASE 3;

ADULT; ARTICLE; CELL FRACTIONATION; CELL FUNCTION; CELL INTERACTION; CELL ISOLATION; CELL TYPE; CLINICAL ARTICLE; CLINICAL PATHWAY; CLONAL ANERGY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; ELECTROPHORESIS; EXOSOME; FEMALE; FETUS CELL; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; PLACENTA; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; STANDARDIZATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TERM BIRTH; TH1 CELL; TH2 CELL; TUMOR CELL CULTURE;

EID: 31144445302     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.3.1534     Document Type: Article

References (48)

1. Challis, J. R. 2001. Understanding pre-term birth. Clin. Invest. Med. 24: 60-67.
2. Haram, K., J. H. S. Mortensen, and A. L. Wollen. 2003. Preterm delivery: an overview. Acta Obstet. Gynecol. Scand. 82: 687-704.
3. Tucker, J., and W. McGuire. 2004. Epidemiology of preterm birth. Br. Med. J. 329: 675-678.
4. Hill, G. B. 1998. Preterm birth: associations with genital and possibly oral microflora. Ann. Periodontal. 3: 222-232.
5. Boggess, K. A. 2005. Pathophysiology of preterm birth: Emerging concepts of maternal infection. Clin. Perinatol. 32: 561-569.
6. Offenbacher, S., S. Lieff, K. A. Boggess, A. P. Murtha, P. N. Madianos, C. M. Champagne, R. G. McKaig, H. L. Jared, S. M. Mauriello, R. L. Auten, Jr., et al. 2001. Maternal periodontitis and prematurity. 1. Obstetric outcome of prematurity and growth restriction. Ann. Periodontal. 61: 164-174.
7. Moore, S., M. Ide, P. Y. Coward, M. Randhawa, E. Borkowska, R. Baylis, and R. F. Wilson. 2004. A prospective study to investigate the relationship between periodontal disease and adverse pregnancy outcome. Br. Dent. J. 197: 251-258.
8. Moreu, G., L. Tellez, and M. Gonzalez-Jaranay. 2005. Relationship between maternal periodontal disease and low birth weight pre-term infants. J. Clin. Periodontol. 32: 622-627.
9. Moore, S., M. Ide, M. Randhawa, J. J. Walker, J. G. Reid, and N. A. Simpson. 2004. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. Br. J. Obstet. Gynecol. 111: 125-132.
10. Varner, M. W., and M. S. Esplin. 2005 Current understanding of genetic factors in preterm birth. BJOG: Int. J. Obstet. Gynecol. 112(Suppl. 1): 28-31.
11. Blidaru, I., F. Zugun, C. Cianga, and E. Carasevici. 2002. Maternal Immunophenotypic profile in normal pregnancy and preterm birth. Rev. Med. Chir. Soc. Med. Na. Din. Iasi. 10: 343-347.
12. Sendag, F., I. M. Itil, M. C. Terek, and H. Yilmaz. 2002. The changes of circulating lymphocyte subpopulation in women with preterm labour: a case-controlled study. Austr. NZ J. Obstet. Gynaecol. 42: 358-361.
13. Pelkonen, A. S., H. Suomalainen, M. Hallman, and M. Turpeinen. 1999. Peripheral blood lymphocyte subpopulations in school children born very preterm. Arch. Dis. Child. Fetal Neonat. Ed. 81: F188-F193.
14. Hill, J. A., and B. C. Choi. 2000. Immunodystrophism: evidence for a novel alloimmune hypothesis for recurrent pregnancy loss involving Th1-type immunity to trophoblasts. Semin. Reprod. Med. 18: 401-405.
15. Darmochwal-Kalarz, D., B. Leszcynska-Gorzelak, J. Rolinski, and J. Oleszezuk. 1999. T helper 1- and T helper 2-type cytokine imbalance in pregnant women with preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 86: 165-170.
16. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
17. Hsu, H. C., D. K. Scott, and J. D. Mountz. 2005. Impaired apoptosis and immune senescence: cause or effect? Immunol. Rev. 205: 130-146.
18. Monleon, I., M. J. Martinez-Lorenzo, L. Monteagudo, P. Lasierra, M. Taules, M. Iturralde, A. Pineiro, M. A. Alava, J. Naval, and A. Anel. 2001. Differential secretion of Fas ligand or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 167: 6736-6744.
19. Martinez-Lorenzo, M. J., A. Anel, S. Gamen, I. Monleon, P. Lasierra, L. Larrad, A. Pineiro, M. A. Alava, and J. Naval. 1999. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163: 1274-1281.
20. Taylor, D. D., and C. Gercel-Taylor. 2005. Tumor-derived exosomes as mediates of T-cell signaling defects. Br. J. Cancer 92: 305-311.
21. Gercel-Taylor, C., S. M. O'Connor, G. K. Lam, and D. D. Taylor. 2002. Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis. J. Reprod. Immunol. 56: 29-44.
22. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
23. Taylor, D. D., S. A. Sullivan, A. C. Eblen, and C. Gercel-Taylor. 2002. Modulation of T-cell CD3-ζ chain expression during normal pregnancy. J. Reprod. Immunol. 54: 15-31.
24. Wegmann, T. G., H. Lin, L. Guilbert, and T. R. Mosmann. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol. Today 14: 353-356.
25. Kersh, E. N., G. J. Kersh, and P. M. Allen. 1999. Partially phosphorylated T cell receptor molecules can inhibit T cell activation. J. Exp. Med. 190: 1627-1636.
26. Shores, E. W., T. Tran, A. Grinberg, C. L. Sommers, H. Shen, and P. E. Love. 1997. Role of the multiple T cell receptor (TCR)-ζ chain signaling motifs in selection of the T cell repertoire. J. Exp. Med. 185: 893-900.
27. Raposo, G., D. Tenza, S. Mecheri, R. Peronet, C. Bonnerot, and C. Desaymard. 1997. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell 8: 2631-2645.
28. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183: 1161-1172.
29. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
30. Brown, R., C. Clugston, P. Burns, A. Edlin, P. Vasey, B. Vojtesek, and S. B. Kaye. 1993. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int. J. Cancer 55: 678-684.
31. Heijnen, H. F. G., A. E. Schiel, R. Fijnheer, H. J. Geuze, and J. J. Sixma. 1999. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α granules. Blood 94: 3791-3799.
32. Thery, C., A. Regnault, J. Garin, J. Wolfers, L. Zitvogel, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1999. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147: 599-610.
33. Wolfers, J., A. Lozier, G. Raposo, A. Regnault, C. Thery, C. Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7: 297-303.
34. Andre, F., N. E. Schartz, N. Chaput, C. Flament, G. Raposo, S. Amigorena, E. Angevin, and L. Zitvogel. 2002. Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 20 (Suppl. 4): A28-A31.
35. Chaput, N., J. Taieb, N. E. Schartz, F. Andre, E. Angevin, and L. Zitvogel. 2004. Exosome-based immunotherapy. Cancer Immunol. Immunother. 53: 234-239.
36. Frangsmyr, L., Baranov, V., O. Nagaeva, U. Stendahl, L. Kjellberg, and L. Mincheva-Nilsson. 2004. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod. 11: 35-41.
37. Abrahams, V. M., S. L. Straszewski-Chavez, S. Guller, and G. Mor. 2004. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod. 10: 55-63.
38. Dolo, V., S. D'Ascenzo, S. Violini, L. Pompucci, C. Festuccia, A. Ginestra, M. L. Vittorelli, S. Canevari, and A. Pavan. 1999. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis 17: 131-140.
39. Griffith, T. S., and T. A. Ferguson. 1997. The role of FasL-induced apoptosis in immune privilege. Immunol. Today 18: 240-244.
40. Vacchio, M. S., and R. J. Hodes. 2005. Fetal expression of Fas ligand is necessary and sufficient for induction of CDS T cell tolerance to the fetal antigen H-Y during pregnancy. J. Immunol. 174: 4657-4661.
41. Morelli, A. E., A. T. Larregina, W. J. Shufesky, M. L. G. Sullivan, D. B. Stolz, G. D. Papworth, A. F. Zahorchak, A. J. Logar, Z. Wang, S. C. Watkines, et al. 2004. Endocytosis, intracellular sorting and processing of exosomes by dendritic cells. Blood 104: 3257-3266.
42. Karlsson, M., S. Lundin, U. Dahlgren, H. Kahu, I. Patterson, and E. Telemo. 2001. "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 31: 2892-2900.
43. Whiteside, T. L. 2002. Tumor-induced death of immune cells: its mechanisms and consequences. Semin. Cancer Biol. 12: 43-50.
44. Rabinowich, H., T. E. Reichert, Y. Kashii, B. R. Gastman, M. C. Bell, and T. L. Whiteside. 1998. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells: implications for altered expression of T cell receptor in tumor associated lymphocytes. J. Clin. Invest. 101: 2579-2588.
45. + regulatory T cell subset. Immunology 112: 38-43.
46. Sanchez-Ramon, S., J. Navarro, C. Aristimuno, M. Rodriguez-Mahou, J. M. Bellon, E. Fernandez-Cruz, and C. de Andres. 2005. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol. Lett. 96: 196-201.
47. Aluvihare, V. R., M. Kallikourdis, and A. G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5: 266-271.
48. Viswanathaw, K., and F. S. Dhabhar. 2005. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc. Nat. Acad. Sci. USA 102: 5808-5813.